RELMADA THERAPEUTICS INC

RLMDNASDAQ

🏆 #3109 by market capEarnings Nov 5US Equity

$3.44▲ $0.09 (+2.69%)

🌅 Pre-market$3.31▼ 3.78%Regular close · extended-hours price shown

🔔

Track RLMD

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 2.7%

7d▲ 5.5%

14d▲ 10.6%

30d▼ 8.6%

ytd▼ 28.7%

1y▲ 48.9%

🏦Market Cap

$367M

Small Cap

📈Revenue Growth (YoY)

0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

—

Insufficient data

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.11

Expected

-0.20

beat

+44.90%

YoY +63.30%

Revenue

Actual

—

Expected

—

Consensus estimates

Recent quarters

Q3 2026

-0.11

beat

Q2 2026

-0.22

miss

Q1 2026

-0.27

miss

Q4 2025

-0.30

miss